Home » Stocks » NBIO

Nascent Biotech Inc. (NBIO)

Stock Price: $0.0625 USD 0.0020 (2.46%)
Updated Jan 13, 2021 3:57 PM EST - Market closed
Market Cap 4.80M
Revenue (ttm) n/a
Net Income (ttm) -4.02M
Shares Out 64.34M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 13
Last Price $0.0625
Previous Close $0.0610
Change ($) 0.0020
Change (%) 2.46%
Day's Open 0.0617
Day's Range 0.0591 - 0.0645
Day's Volume 67,592
52-Week Range 0.0437 - 0.35

News

There are no news available yet.

About NBIO

Nascent Biotech, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as lung and breast cancer metastases to the brain; and pancreatic cancer. The company has a research collaboration agreement with Manhattan BioSolutions, Inc. to initiate a vaccine program for the prevention of COVID-19 or other viral infections; and a co... [Read more...]

Industry
Biotechnology
CEO
Sean Carrick
Stock Exchange
OTCMKTS
Ticker Symbol
NBIO
Full Company Profile

Financial Performance

Financial Statements